Gilead Sciences (GILD) Total Debt (2009 - 2026)
Gilead Sciences (GILD) posted Total Debt of $26.25 billion for Q2 2026, up 5.2% from $24.95 billion a year earlier and up 18.4% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Total Debt (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences' Total Debt came in at $24.94 billion, down 6.6% from FY2024.
- Annual Total Debt shows a five-year compound annual growth rate of -4.5% (FY2020 to FY2025).
- In prior years, Gilead Sciences' Total Debt was $26.71 billion in FY2024 (+6.9%), $24.99 billion in FY2023 (-1.0%), $25.23 billion in FY2022 (-5.5%) and $26.7 billion in FY2021 (-15.0%).
- The Q2 2026 figure stands as the highest quarterly Total Debt since Q4 2024.
- On a year-over-year basis, Total Debt increased in four of the last eight quarters, with growth averaging 0.1%.
- The strongest year-over-year quarter for Total Debt in the past five years was Q3 2025, with growth of 7.3%; the weakest was Q4 2021, with a decline of 15.0%.
- According to Business Quant data, Total Debt for the three prior quarters was $22.17 billion (Q1 2026), $24.94 billion (Q4 2025) and $24.94 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 49.04 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 37.49 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -111.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.25 Bn |
| Mar 31, 2026 | 22.17 Bn |
| Dec 31, 2025 | 24.94 Bn |
| Sep 30, 2025 | 24.94 Bn |
| Jun 30, 2025 | 24.95 Bn |
| Mar 31, 2025 | 24.95 Bn |
| Dec 31, 2024 | 26.71 Bn |
| Sep 30, 2024 | 23.25 Bn |
| Jun 30, 2024 | 23.35 Bn |
| Mar 31, 2024 | 25.19 Bn |
| Dec 31, 2023 | 24.99 Bn |
| Sep 30, 2023 | 24.98 Bn |
| Jun 30, 2023 | 25.25 Bn |
| Mar 31, 2023 | 25.24 Bn |
| Dec 31, 2022 | 25.23 Bn |
| Sep 30, 2022 | 25.22 Bn |
| Jun 30, 2022 | 26.22 Bn |
| Mar 31, 2022 | 26.21 Bn |
| Dec 31, 2021 | 26.70 Bn |
| Sep 30, 2021 | 27.69 Bn |
API Access
Gilead Sciences Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();